A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism. (22nd March 2019)

• Record Type: Journal Article
• Authors: Xiao, Libin; Jiang, Yiran; Zhang, Cui; Jiang, Lei; Zhou, Weiwei; Su, Tingwei; Ning, Guang; Wang, Weiqing
• Is Part Of: Clinical endocrinology. Volume 90:Number 6(2019)
• Page Start: 781
• Page End: 788
• Publication Date: 2019-03-22
• Subjects: nomogram -- prediction -- primary aldosteronism -- subtype diagnosis; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1111/cen.13962
• Languages: English
• ISSNs: 0300-0664

Abstract

Summary: Context: Adrenal venous sampling (AVS) is recommended as the gold standard for subtype classification in primary aldosteronism (PA); however, this approach has limited availability. Objective: We aimed to develop a novel clinical nomogram to predict PA subtype based on routine variables, thereby reducing the number of candidates for AVS. Patients and method: Patients were randomly divided into a training set (n = 185) and a validation set (n = 79). Risk factors for idiopathic hyperaldosteronism (IHA) differentiating from aldosterone‐producing adenoma (APA) were identified using logistic regression analysis. A nomogram was constructed to predict the probability of IHA. A receiver operating characteristic (ROC) curve and a calibration plot were applied to assess the predictive value. Then, 115 patients were prospectively enrolled, and a nomogram was used to predict the subtypes before AVS. Results: Body mass index (BMI), serum potassium and computed tomography (CT) finding were adopted in the nomogram. The nomogram presented an area under the ROC (AUC) of 0.924 (95% CI: 0.875‐0.957), sensitivity of 86.59% and specificity of 87.38% in the training set and an AUC of 0.894 (95% CI: 0.804‐0.952), sensitivity of 82.86% and specificity of 84.09% in the validation set. Predicted probability and actual probability matched well in the nomogram (Hosmer‐Lemeshow test: P > 0.05). Using the nomogram as a surrogate to predict IHA in the prospective set before AVS, the specificity reached 100% when we increased the threshold to a probability of 90%. Conclusion: We have developed a tool that is able to predict IHA in patients with PA and potentially avoid AVS.